We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$5.45B
AUM Growth
+$268M
Cap. Flow
+$5.47M
Cap. Flow %
0.1%
Top 10 Hldgs %
35.74%
Holding
946
New
25
Increased
88
Reduced
168
Closed
176

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$21.1M
2
CELG
Celgene Corp
CELG
+$8.69M
3
BKNG icon
Booking.com
BKNG
+$7.22M
4
ADBE icon
Adobe
ADBE
+$3.62M
5
STMP
Stamps.com, Inc.
STMP
+$3.54M

Top Sells

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$8.34M
2
RTX icon
RTX Corp
RTX
+$7.02M
3
MA icon
Mastercard
MA
+$4.51M
4
GILD icon
Gilead Sciences
GILD
+$4.33M
5
UNFI icon
United Natural Foods
UNFI
+$4.12M

Sector Composition

Rank Sector Weight
1 Technology 25.73%
2 Healthcare 17.8%
3 Consumer Staples 10.65%
4 Financials 9.43%
5 Consumer Discretionary 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPB icon
526
Campbell Soup
CPB
$6.9B
$18K ﹤0.01%
373
GRX
527
Gabelli Healthcare & Wellness Trust
GRX
$147M
$18K ﹤0.01%
1,770
LH icon
528
Labcorp
LH
$26.1B
$18K ﹤0.01%
134
-174
-56% -$23K
MPT
529
Medical Properties Trust
MPT
$2.44B
$18K ﹤0.01%
1,300
-72
-5% -$973
WM icon
530
Waste Management
WM
$90.1B
$18K ﹤0.01%
208
VAR
531
DELISTED
Varian Medical Systems, Inc.
VAR
$18K ﹤0.01%
160
DATA
532
DELISTED
Tableau Software, Inc.
DATA
$18K ﹤0.01%
265
CSX icon
533
CSX Corp
CSX
$93.5B
$17K ﹤0.01%
900
-2,310
-72% -$40.9K
EQNR icon
534
Equinor
EQNR
$96B
$17K ﹤0.01%
800
FWONK icon
535
Liberty Media Series C
FWONK
$26B
$17K ﹤0.01%
517
-21
-4% -$759
SPLV icon
536
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
$17K ﹤0.01%
352
MTOR
537
DELISTED
MERITOR, Inc.
MTOR
$17K ﹤0.01%
741
PARA
538
DELISTED
Paramount Global Class B
PARA
$16K ﹤0.01%
270
-4
-1% -$230
AMX icon
539
America Movil
AMX
$70.1B
$14K ﹤0.01%
843
ATNI icon
540
ATN International
ATNI
$494M
$14K ﹤0.01%
250
CRSP icon
541
CRISPR Therapeutics
CRSP
$5.19B
$14K ﹤0.01%
600
DELL icon
542
Dell
DELL
$322B
$14K ﹤0.01%
609
HUBB icon
543
Hubbell
HUBB
$26.8B
$14K ﹤0.01%
100
HXL icon
544
Hexcel
HXL
$7.68B
$14K ﹤0.01%
222
MANH icon
545
Manhattan Associates
MANH
$11.3B
$14K ﹤0.01%
280
-13
-4% -$583
MET icon
546
MetLife
MET
$61.5B
$14K ﹤0.01%
283
-15
-5% -$790
PANW icon
547
Palo Alto Networks
PANW
$318B
$14K ﹤0.01%
600
TFC icon
548
Truist Financial
TFC
$64.6B
$14K ﹤0.01%
279
+265
+1,893% +$12.8K
TRV icon
549
Travelers Companies
TRV
$77B
$14K ﹤0.01%
101
XLRN
550
DELISTED
Acceleron Pharma
XLRN
$14K ﹤0.01%
337

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Loring Wolcott & Coolidge Fiduciary Advisors held 946 positions worth $5.45B, up 5.2% from $5.18B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2017 filing shows 25 new, 88 increased, 168 reduced and 176 closed positions. Its largest new stake was Veeva Systems: 6,655 shares worth $368K. The largest sale was Warner Bros, an estimated $8.34M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2017 buy was Veeva Systems: 6,655 shares worth $368K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Analog Devices in Q4 2017, an estimated $21.1M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2017 reduction was Warner Bros, cutting an estimated $8.34M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $441K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 36% of its $5.45B portfolio in Q4 2017.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 25 new positions and closed 176 in Q4 2017.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 5.2% quarter-over-quarter to $5.45B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2017, filed 8 Feb 2018.